LEI NIE to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications LEI NIE has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.210
-
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial. Signal Transduct Target Ther. 2024 Dec 24; 9(1):369.
Score: 0.070
-
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. 2024 Sep 09; 42(9):1598-1613.e4.
Score: 0.069
-
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). J Clin Oncol. 2023 01 20; 41(3):651-663.
Score: 0.060
-
Targeting PKCd as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 12 10; 34(6):954-969.e4.
Score: 0.012